文献速递肝病

青春期胆道闭锁患者成年期需肝移植的预后标志物

Prognostic markers at adolescence in patients requiring liver transplantation for biliary atresia in adulthood.
PubMed 文献 · J Hepatol · 2019-03-13

该单中心回顾性研究分析1980-96年英国397例Kasai门肠吻合术患者,其中111例16岁时自体肝存活,最终67例>16岁仍自体肝存活(组1),22例>16岁需肝移植(组2)。多因素分析显示16岁时总胆红素较高(HR 1.03,p=0.019)和肌酐较低(HR 0.95,p=0.040)与>16岁需肝移植相关;总胆红素≥21 µmol/L预测>16岁需肝移植的AUROC为0.848,敏感性85%、特异性74%。青春期胆管炎发作使>16岁需肝移植风险增加5倍,<16岁存在门静脉高压或胃食管静脉曲张分别使风险增加7倍和8.6倍。

要点

  • 16岁时总胆红素≥21 µmol/L可预测胆道闭锁患者>16岁需肝移植,敏感性85%、特异性74%。
  • 青春期胆管炎发作使>16岁需肝移植风险增加5倍。
  • <16岁存在门静脉高压或胃食管静脉曲张分别使需肝移植风险增加7倍和8.6倍。

核心结论

  • 成年期胆道闭锁需要专科管理,成人肝病评分模型不适用于该队列。
  • 16岁时胆红素≥21 µmol/L、门静脉高压或胃食管静脉曲张,以及青春期胆管炎,可预测胆道闭锁年轻患者未来需肝移植。
  • 16岁时低肌酐也具有潜在预后价值。

研究设计与样本

  • 单中心回顾性分析,纳入1980-96年英国397例接受Kasai门肠吻合术的患者。
  • 术后111/397(28%)例16岁时自体肝存活;最终随访时67例>16岁仍自体肝存活(组1),22例>16岁需肝移植(组2)。
  • 两组在中位年龄16.06岁(13.6-17.4岁)时收集实验室、临床和影像学参数。

主要发现

  • 多因素分析显示>16岁需肝移植与16岁时较高的总胆红素(HR 1.03,p=0.019)和较低的肌酐(HR 0.95,p=0.040)相关。
  • ROC曲线分析显示16岁时总胆红素≥21 µmol/L预测>16岁需肝移植的AUROC为0.848,敏感性85%、特异性74%。
  • 青春期胆管炎发作与>16岁需肝移植风险增加5倍相关。
  • <16岁存在门静脉高压或胃食管静脉曲张分别与需肝移植风险增加7倍和8.6倍相关。

关键数值与推荐

  • 16岁时总胆红素≥21 µmol/L预测>16岁需肝移植:AUROC=0.848,敏感性85%,特异性74%。
  • 16岁时总胆红素每升高1单位,>16岁需肝移植的HR为1.03(p=0.019)。
  • 16岁时肌酐每升高1单位,>16岁需肝移植的HR为0.95(p=0.040)。
  • 青春期胆管炎发作使>16岁需肝移植风险增加5倍。
  • <16岁门静脉高压使需肝移植风险增加7倍,胃食管静脉曲张使风险增加8.6倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: In patients with biliary atresia (BA), the rate of native liver survival (NLS) to adulthood has been reported as 14-44% worldwide. Complications related to portal hypertension (PHT) and cholangitis are common in adulthood. For those requiring liver transplantation (LT), the timing can be challenging. The aim of this study was to identify variables that could predict whether young people with BA would require LT when they are >16 years of age. METHODS: This study was a single-centre retrospective analysis of 397 patients who underwent Kasai portoenterostomy (KP) between 1980-96 in the UK. After KP, 111/397 (28%) demonstrated NLS until 16 years of age. At final follow-up, 67 showed NLS when >16 years old (Group 1) and 22 required LT when >16 years old (Group 2). Laboratory, clinical and radiological parameters were collected for both groups at a median age of 16.06 years (13.6-17.4 years). RESULTS: The need for LT when >16 years old was associated with higher total bilirubin (hazard ratio 1.03, p = 0.019) and lower creatinine (hazard ratio 0.95, p = 0.040), at 16 years, on multivariate analysis. Receiver-operating characteristic curve analysis demonstrated that a total bilirubin level of ≥21 µmol/L at 16 years old (AUROC = 0.848) predicted the need for LT when >16 years old, with 85% sensitivity and 74% specificity. Cholangitis episode(s) during adolescence were associated with a 5-fold increased risk of needing LT when >16 years old. The presence of PHT or gastro-oesophageal varices in patients <16 years old was associated with a 7-fold and 8.6-fold increase in the risk of needing LT, respectively. CONCLUSIONS: BA in adulthood requires specialised management. Adult liver disease scoring models are not appropriate for this cohort. Bilirubin ≥21 µmol/L, PHT or gastro-oesophageal varices at 16 years, and cholangitis in adolescence, can predict the need for future LT in young people with BA. Low creatinine at 16 years also has potential prognostic value. LAY SUMMARY: Patients with biliary atresia commonly require liver transplantation before reaching adulthood. Those who reach adulthood with their own liver are still at risk of needing a transplant. This study aimed to identify tests that could help clinicians predict which patients with biliary atresia who reach the age of 16 without a transplant will require one in later life. The study found that the presence of bilirubin ≥21 µmol/L, lower creatinine levels, and a history of portal hypertension or gastro-oesophageal varices at 16 years, as well as cholangitis in adolescence, could predict the future likelihood of needing a liver transplant for young people with biliary atresia.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Jain V, Burford C, Alexander EC, et al. Prognostic markers at adolescence in patients requiring liver transplantation for biliary atresia in adulthood. J Hepatol. 2019. PMID: 30876944. doi:10.1016/j.jhep.2019.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。